Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life
You might also like
Freeline Therapeutics Updates Clinical Development Plan for its FLT180a Hemophilia B Program
Freeline Announces Orphan Drug Designations for FLT201 for the Treatment of Gaucher Disease
Freeline Publishes Preclinical Proof-of-Concept Data for FLT190, its AAV Gene Therapy Candidate for Fabry Disease, in the Nature Journal Gene Therapy
Freeline Therapeutics to Present FLT180a Data at the 2021 ASH Annual Meeting
Freeline to participate at Conferences during January 2021
Acquisition of Freeline by Syncona Becomes Effective
Get in touch

+44 (0)1438 906870
contact@freeline.life

Follow us on our social channels